Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events Academic Article uri icon

Overview

MeSH Major

  • Anti-HIV Agents
  • Antiretroviral Therapy, Highly Active
  • HIV Infections

abstract

  • Efavirenz-related CNS adverse events were not associated with predicted neurotransmitter transporter/receptor gene expression levels in brain or with polymorphisms in these genes. Variable susceptibility to efavirenz-related CNS adverse events may not be explained by brain neurotransmitter transporter/receptor genomics.

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC6010221

Digital Object Identifier (DOI)

  • 10.1097/FPC.0000000000000341

PubMed ID

  • 29847509

Additional Document Info

start page

  • 179

end page

  • 187

volume

  • 28

number

  • 7